Skip to main content
OpenTrials
Completed

NCT Number: NCT06141330

Vitamin D Supplementation in Acne

The goal of this clinical trial is to compare in acne vulgaris patients. The main question it aims to answer is:

• To assess the therapeutic benefit of vitamin D supplement in acne vulgaris treatment, following a 2-month treatment regimen that includes vitamin D supplementation compared to conventional (systemic azithromycin and topical retinoid) treatment alone.

Participants will receive vitamin D supplements in addition to capsule Azithromycin and topical retinoid.

Researchers will compare groups to determine efficacy of Vitamin D supplements in the treatment of Acne vulgaris.

Completed

Looking for future studies?

Notify Me

Key information

Age range

13 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hitec-Ims

Islamabad, Punjab Province, 47080, Pakistan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals aged between 13 and 40 years with diagnoses of Acne vulgaris are included.

Exclusion criteria

  • Individuals currently undergoing treatment for polycystic ovary syndrome (PCOs)
  • Those with obesity
  • Individuals employing vitamin supplementation
  • Those under the influence of topical or systemic steroids and acne treatment in the last 2 months.

Treatment and study plan

D Max Drops

Dietary Supplement

Vitamin D

Azithromycin 250 milligram Oral Capsule

Drug

Anti Biotic

Adapalene

Drug

Retinoid

Primary outcomes

  1. Efficacious

    Time frame: 2 months

    Improvement in Global Acne Grading System Score from baseline to after 2 months of treatment

Sponsors and collaborators

Lead sponsor

HITEC-Institute of Medical Sciences

Other

Registry information

Official study title

Vitamin D Supplementation in Combination With Azithromycin and Topical Retinoid for Acne: A Randomized Controlled Trial

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Nov 21, 2023
Registry last updated
May 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.